Evaluating the Pharmacodynamic Noninferiority of Efgartigimod PH20 SC Administered Subcutaneously as Compared to Efgartigimod Administered Intravenously in Patients With Generalized Myasthenia Gravis
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Generalized Myasthenia Gravis
Related studies linked through entity extraction aliases.
A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis
- Status
- COMPLETED
- Phase
- PHASE3
Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Status
- RECRUITING
- Phase
- N/A
A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Test Efficacy and Safety of Rozanolixizumab in Adult Patients With Generalized Myasthenia Gravis
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy Study of Ravulizumab in Adults With Generalized Myasthenia Gravis
- Status
- COMPLETED
- Phase
- PHASE3
An Extension Study of MOM-M281-004 to Evaluate the Safety, Tolerability, and Efficacy of M281 Administered to Patients With Generalized Myasthenia Gravis
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis
- Status
- COMPLETED
- Phase
- PHASE2
A Safety and Tolerability Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness.
- Status
- COMPLETED
- Phase
- PHASE3
An Efficacy and Safety Study of ARGX-113 in Patients With Myasthenia Gravis Who Have Generalized Muscle Weakness
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis
- Status
- COMPLETED
- Phase
- PHASE2
A Study Evaluating the Safety and Efficacy of Rituximab in Patients With Myasthenia Gravis
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety Study of GB-0998 for Treatment of Generalized Myasthenia Gravis
- Status
- COMPLETED
- Phase
- PHASE3